Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Journal of Insurance Medicine (New York, N.Y.)|November 2, 2005
Practical cancer genetics, genomics and proteomicsMichael P Gruber, Mark W GeraciTransactions of the American Clinical and Climatological Association|September 1, 2018
TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTIONMark W GeraciPulmonary Circulation|May 11, 2013
Integrating molecular genetics and systems approaches to pulmonary vascular diseasesMark W GeraciHeart Failure Clinics|December 1, 2009
Genomics of pulmonary arterial hypertension: implications for therapyMark W Geraci, Todd M Bull, Rubin M TuderAmerican Journal of Respiratory Cell and Molecular Biology|February 25, 2006
Human lung project: evaluating variance of gene expression in the human lungMichael P Gruber, Christopher D Coldren, Malcolm D Woolum, et al.Proceedings of the American Thoracic Society|January 5, 2007
Gene expression profiling in pulmonary hypertensionTodd M Bull, Christopher D Coldren, Mark W Geraci, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent mannerDerek Strassheim, Suzzette R Riddle, Danielle L Burke, et al.Free Radical Biology & Medicine|May 16, 2012
Promoter G-quadruplex sequences are targets for base oxidation and strand cleavage during hypoxia-induced transcriptionDavid W Clark, Tzu Phang, Michael G Edwards, et al.Cancer Research|January 4, 2008
A macrophage gene expression signature defines a field effect in the lung tumor microenvironmentRobert S Stearman, Lori Dwyer-Nield, Michael C Grady, et al.Molecular Cancer Research : MCR|March 22, 2007
Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell linesRobert S Stearman, Michael C Grady, Patrick Nana-Sinkam, et al.Pageof 8